Otonomy Announces Launch of Follow-on Public Offering
January 21 2015 - 4:01PM
Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical
company focused on the development and commercialization of
innovative therapeutics for diseases and disorders of the inner and
middle ear, today announced the launch of its proposed follow-on
public offering of approximately $75 million of its common stock.
All shares of common stock to be sold in the offering will be
offered by Otonomy. In addition, Otonomy expects to grant the
underwriters a 30-day option to purchase up to an additional
approximately $11 million of its common stock.
J.P. Morgan Securities LLC is acting as the sole book-running
manager for the offering, Piper Jaffray & Co. and Cowen and
Company, LLC are acting as lead managers, and Sanford C. Bernstein
& Co., LLC is acting as co-manager.
A registration statement relating to these securities has been
filed with the SEC, but has not yet become effective. These
securities may not be sold, nor may offers to buy be accepted,
prior to the time the registration statement becomes effective.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
The offering will be made only by means of a prospectus. When
available, copies of the preliminary prospectus may be obtained
from J.P. Morgan Securities LLC, Attention: Broadridge Financial
Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by
telephone at (866) 803-9204.
CONTACT: Media Inquiries
Canale Communications
Heidi Chokeir, Ph.D.
Vice President
619.849.5377
heidi@canalecomm.com
Investor Inquiries
Westwicke Partners
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024